Volume 66, Issue 5 pp. 659-665

Endogenous corticosteroid biosynthesis in subjects after bilateral adrenalectomy

E. M. Freel

E. M. Freel

Glasgow Cardiovascular Research Centre, University of Glasgow, UK,

Search for more papers by this author
M. Bernhardt

M. Bernhardt

Glasgow Cardiovascular Research Centre, University of Glasgow, UK,

Search for more papers by this author
R. Ingram

R. Ingram

Department of Biochemistry, Saarland University, Saarbrucken, Germany and

Search for more papers by this author
A. M. Wallace

A. M. Wallace

Department of Biochemistry, McEwan Building, Glasgow Royal Infirmary, Glasgow, UK

Search for more papers by this author
R. Fraser

R. Fraser

Glasgow Cardiovascular Research Centre, University of Glasgow, UK,

Search for more papers by this author
E. Davies

E. Davies

Glasgow Cardiovascular Research Centre, University of Glasgow, UK,

Search for more papers by this author
J. M. C. Connell

J. M. C. Connell

Glasgow Cardiovascular Research Centre, University of Glasgow, UK,

Search for more papers by this author
First published: 23 March 2007
Citations: 9
John Connell, Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK. Tel.: + 44 0141 211 2108; Fax: + 44 0141 211 1763; E-mail: [email protected]

Summary

Objective Corticosteroids can be synthesized in extra-adrenal tissues but the contribution of this to circulating levels in humans is not known. Previous in vitro studies suggest that the ‘hybrid’ corticosteroid 18-oxocortisol (18-oxoF) is produced from cortisol by aldosterone synthase. We looked for evidence of extra-adrenal production of this and other corticosteroids in 10 subjects stable on long-term glucocorticoid replacement following bilateral adrenalectomy.

Methods In phase 1, patients were maintained on cortisol alone (30 mg/day), in phase 2 dexamethasone (2 mg/day), and in phase 3, both cortisol and dexamethasone. Each phase lasted 3 days.

Measurements On the last day of each phase, 24-h urine collection was performed for analysis of steroid metabolite excretion [using gas chromatography–mass spectrometry (GCMS)] and plasma aldosterone and renin were measured (by radioimmunoassay).

Results Cortisol metabolite excretion rate [tetrahydrocortisone (THE) + tetrahydrocortisol (THF) + allotetrahydrocortisol (aTHF)] fell from 9169 nmol/24 h in phase 1 to 22 nmol/24 h in phase 2, rising to 6843 nmol/24 h in phase 3. Tetrahydroaldosterone (THAldo) excretion was readily detectable and did not alter significantly between phases (26·5, 23·5 and 28·5 nmol/24 h, respectively; P = 0·474). 18-Hydroxycortisol (18-OHF) excretion was easily detectable in phases 1 and 3 (252·5 and 212 nmol/24 h), falling in phase 2 (12 nmol/24 h). 18-oxoF excretion rates were lower but followed a similar pattern (1·62, 0·085 and 1·785 nmol/24 h in phases 1, 2 and 3, respectively).

Conclusions Significant levels of adrenal steroids are found in adrenalectomized subjects. We speculate that this occurs at extra-adrenal sites or in residual adrenal cortex tissue in an ACTH-independent manner. Our data suggest that aldosterone synthase, acting on cortisol, is the source of 18-oxoF and 18-OHF in these subjects. Further studies of corticosteroid production within adrenalectomized subjects, looking for evidence of adrenal regrowth or residual adrenal tissue, are justified.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.